Skip to main content

Table 2 Proportion of patients with each type of hypnotic prescribed before the incidence of each outcome

From: Hypnotics and injuries among older adults with Parkinson’s disease: a nested case–control design

  

Injury

  

Yes

(%)

No

(%)

P

Total

  

3343

(66.7)

1666

(33.3)

 

5009

Benzodiazepines

   

0.000

 
 

Yes

110

(53.4)

96

(46.6)

 

206

 

No

3233

(67.3)

1570

(32.7)

 

4803

Non-benzodiazepines

  

0.000

 
 

Yes

99

(47.8)

108

(52.2)

 

207

 

No

3244

(67.6)

1558

(32.4)

 

4802

Melatonin receptor agonists

  

0.009

 
 

Yes

43

(53.1)

38

(46.9)

 

81

 

No

3300

(67.0)

1628

(33.0)

 

4928

Orexin receptor antagonists

  

0.000

 
 

Yes

43

(43.4)

56

(56.6)

 

99

 

No

3300

(67.2)

1610

(32.8)

 

4910

  

Fracture

  

Yes

(%)

No

(%)

P

Total

  

1894

(37.8)

3115

(62.2)

 

5009

Benzodiazepines

   

0.000

 
 

Yes

67

(23.3)

221

(76.7)

 

288

 

No

1827

(38.7)

2894

(61.3)

 

4721

Non-benzodiazepines

  

0.000

 
 

Yes

67

(24.3)

209

(75.7)

 

276

 

No

1827

(38.6)

2906

(61.4)

 

4733

Melatonin receptor agonists

  

0.000

 
 

Yes

29

(22.0)

103

(78.0)

 

132

 

No

1865

(38.2)

3012

(61.8)

 

4877

Orexin receptor antagonists

  

0.000

 
 

Yes

30

(19.4)

125

(80.6)

 

155

 

No

1864

(38.4)

2990

(61.6)

 

4854

  

Femoral fracture

  

Yes

(%)

No

(%)

P

Total

  

512

(10.2)

4497

(89.8)

 

5009

Benzodiazepines

   

0.007

 
 

Yes

24

(6.2)

362

(93.8)

 

386

 

No

488

(10.6)

4135

(89.4)

 

4623

Non-benzodiazepines

  

0.008

 
 

Yes

23

(6.2)

347

(93.8)

 

370

 

No

489

(10.5)

4150

(89.5)

 

4639

Melatonin receptor agonists

  

0.109

 
 

Yes

12

(6.7)

168

(93.3)

 

180

 

No

500

(10.4)

4329

(89.6)

 

4829

Orexin receptor antagonists

  

0.009

 
 

Yes

10

(4.8)

197

(95.2)

 

207

 

No

502

(10.5)

4300

(89.5)

 

4802